What Affects Treatment Underuse in Multiple Myeloma in the United States: A Qualitative Study

SIMPLE SUMMARY: Multiple myeloma is the second most common hematologic malignancy. Diagnosis, treatment, and survival rates vary by race, which suggests that race may influence access to or reception of treatment. This study sought to understand multiple myeloma patients’ treatment experiences and f...

Descripción completa

Detalles Bibliográficos
Autores principales: Cytryn, Rose, Bickell, Nina, Yagnik, Radhi, Jagannath, Sundar, Lin, Jenny J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137271/
https://www.ncbi.nlm.nih.gov/pubmed/37190297
http://dx.doi.org/10.3390/cancers15082369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137271/
https://www.ncbi.nlm.nih.gov/pubmed/37190297
http://dx.doi.org/10.3390/cancers15082369

Ejemplares similares